Advertisement

Doesn’t metoclopramide allow a significant decrease in antacid consumption?

  • G. Cargill
Conference paper

Abstract

Metoclopramide, by its action on the inferior esophageal sphincter, and on the motility of the lower esophagus, decreases the incidence of gastroesophageal reflux. It is therefore logical to think that this substance may permit reduction in the intake of antacids.

Keywords

Gastroesophageal Reflux Benign Lesion Reverse Order Lower Esophagus Average Daily Dose 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    McCallum RW et al. (1977) A controlled trial of Metoclopramide in symptomatic gastroesophageal reflux. New Engl J Med 296, 7:354–357PubMedCrossRefGoogle Scholar
  2. 2.
    Bright-Asare P, El Bassoussi M (1980) Cimetidine, Metoclopramide or placebo in the treatment of symptomatic gastroesophageal reflux. J Clin Gastroenterology, 149–156Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • G. Cargill
    • 1
  1. 1.ParisFrance

Personalised recommendations